Angiotensin Receptor-Neprilysin Inhibitor Suppresses Renin-Angiotensin-Aldosterone System Activation After Cardiac Surgery Using Cardiopulmonary Bypass
Circulation Journal · 2024
DOI: 10.1253/circj.cj-23-0879 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Circulation Journal, 2024. Verfasst von Joji Hoshino und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac and Vascular Surgery, Dokkyo Medical University. Hauptthemen laut MEDLINE: Neprilysin, Valsartan, Cardiopulmonary Bypass, Renin-Angiotensin System. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Sacubitril/valsartan, being both a neprilysin inhibitor and angiotensin receptor blocker, exhibits a renin-angiotensin-aldosterone system (RAAS) inhibitory effect. However, no study has investigated the administration of sacubitril/valsartan in patients early after surgery using cardiopulmonary bypass. METHODS AND RESULTS: This was a prospective observational study of 63 patients who underwent open heart surgery and were treated with sacubitril/valsartan. No serious adverse events occurred. Among the 63 patients, sacubitril/valsartan was discontinued in 13 due to hypotension (n=10), renal dysfunction (n=2), and dizziness (n=1). Atrial natriuretic peptide concentrations increased significantly from Day 3 of treatment (P=0.0142 vs. Postoperative Day 1) and remained high thereafter. In contrast, plasma renin activity was significantly suppressed from Day 3 onwards (P=0.00206 vs. Postoperative Day 1). A decrease in creatinine concentrations and an increase in the estimated glomerular filtration rate were observed on Day 3; this improvement in renal function was not observed in the historical control group, in which patients did not receive sacubitril/valsartan. New postoperative atrial fibrillation was less frequent in the study group compared with the historical control (12.7% vs. 38.0%; P=0.0034). CONCLUSIONS: Sacubitril/valsartan administration was safe immediately after open heart surgery in patients without postoperative hypotension. It enhanced serum atrial natriuretic peptide concentrations and suppressed RAAS activation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiac and Vascular Surgery, Dokkyo Medical University.
- Department of Cardiovascular Surgery, Gunma Prefectural Cardiovascular Center.
- Medical Science of Nursing, School of Nursing, Dokkyo Medical University.
Zitieren
APA
Hoshino, J., Saito, S., Shibasaki, I., Sairenchi, T., Okubo, S., Matsuoka, T., Hirota, S., Yokoyama, S., Kanazawa, Y., Tezuka, M., Takei, Y., Tsuchiya, G., Konishi, T., Ogata, K., & Fukuda, H. (2024). Angiotensin Receptor-Neprilysin Inhibitor Suppresses Renin-Angiotensin-Aldosterone System Activation After Cardiac Surgery Using Cardiopulmonary Bypass. Circulation Journal. https://doi.org/10.1253/circj.cj-23-0879
Vancouver
Hoshino J, Saito S, Shibasaki I, Sairenchi T, Okubo S, Matsuoka T, et al. Angiotensin Receptor-Neprilysin Inhibitor Suppresses Renin-Angiotensin-Aldosterone System Activation After Cardiac Surgery Using Cardiopulmonary Bypass. Circulation Journal. 2024. doi:10.1253/circj.cj-23-0879
BibTeX
@article{Hoshino2024,
author = {Hoshino, Joji and Saito, Shunsuke and Shibasaki, Ikuko and Sairenchi, Toshimi and Okubo, Shohei and Matsuoka, Taiki and Hirota, Shotaro and Yokoyama, Shohei and Kanazawa, Yuta and Tezuka, Masahiro and Takei, Yusuke and Tsuchiya, Go and Konishi, Taisuke and Ogata, Koji and Fukuda, Hirotsugu},
title = {Angiotensin Receptor-Neprilysin Inhibitor Suppresses Renin-Angiotensin-Aldosterone System Activation After Cardiac Surgery Using Cardiopulmonary Bypass},
journal = {Circulation Journal},
year = {2024},
doi = {10.1253/circj.cj-23-0879}
}
EUVIMED